Thus, a plasmid containing shRNA for the Birc5 gene could enter the cell, decrease Birc5 gene transcription in a targeted manner, promote tumor cell apoptosis, and reduce angiogenesis without affecting normal cells. This evidence concerns the gene BIRC5 and neoplasm.